FDA Inspection 1278327 — Kaiser Permanente Center For Reproductive Health

Kaiser Permanente Center For Reproductive Health — FEI 3006304159

The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on August 7, 2025 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 7, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Sacramento, CA (United States)